IMU 3.39% 5.7¢ imugene limited

Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-90

  1. 2,736 Posts.
    lightbulb Created with Sketch. 1062
    I suspect that IMU is paying for this phase and if it looks good, I think that Merck/Pfizer may take control of a Phase 3 trial as they will most likely want more control and they have much bigger teams and resources and connections to draw upon.
    Case of IMU strutting their stuff and impressing Big Pharma.
    Good move I think.
    Just the start of potential partnerships.

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.7¢
Change
-0.002(3.39%)
Mkt cap ! $418.9M
Open High Low Value Volume
6.0¢ 6.2¢ 5.6¢ $1.863M 31.44M

Buyers (Bids)

No. Vol. Price($)
3 214965 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.8¢ 60000 1
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.